288 related articles for article (PubMed ID: 32002597)
1. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.
Dhanesh VV; Hosamani M; Basagoudanavar SH; Saravanan P; Biswal JK; Tamil Selvan RP; Madhavan A; Sehrish K; Sanyal A; Sreenivasa BP
Appl Microbiol Biotechnol; 2020 Mar; 104(6):2589-2602. PubMed ID: 32002597
[TBL] [Abstract][Full Text] [Related]
2. Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.
Ranjitha HB; Dhanesh VV; Hosamani M; Sreenivasa BP; Jabeen U; Biswal JK; Saravanan P; Sanyal A; Bhanuprakash V; Basagoudanavar SH
Appl Microbiol Biotechnol; 2023 Feb; 107(4):1285-1297. PubMed ID: 36656322
[TBL] [Abstract][Full Text] [Related]
3. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.
Li P; Lu Z; Bai X; Li D; Sun P; Bao H; Fu Y; Cao Y; Chen Y; Xie B; Yin H; Liu Z
Vet Res; 2014 May; 45(1):51. PubMed ID: 24885414
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus.
Bhatt M; Mohapatra JK; Pandey LK; Mohanty NN; Das B; Prusty BR; Pattnaik B
Virus Res; 2018 Jan; 243():36-43. PubMed ID: 29037477
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
Neilan JG; Schutta C; Barrera J; Pisano M; Zsak L; Hartwig E; Rasmussen MV; Kamicker BJ; Ettyreddy D; Brough DE; Butman BT; Brake DA
BMC Vet Res; 2018 Aug; 14(1):254. PubMed ID: 30157853
[TBL] [Abstract][Full Text] [Related]
7. Infection and protection responses of deletion mutants of non-structural proteins of foot-and-mouth disease virus serotype Asia1 in guinea pigs.
Lalzampuia H; Elango S; Biswal JK; Krishnaswamy N; Selvan RPT; Saravanan P; Mahadappa P; V Umapathi ; Reddy GR; Bhanuprakash V; Sanyal A; Dechamma HJ
Appl Microbiol Biotechnol; 2022 Jan; 106(1):273-286. PubMed ID: 34889988
[TBL] [Abstract][Full Text] [Related]
8. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
10. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
11. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
[TBL] [Abstract][Full Text] [Related]
12. A mutant of Asia 1 serotype of Foot-and-mouth disease virus with the deletion of an important antigenic epitope in the 3A protein.
Li S; Gao M; Zhang R; Song G; Song J; Liu D; Cao Y; Li T; Ma B; Liu X; Wang J
Can J Microbiol; 2011 Mar; 57(3):169-76. PubMed ID: 21358757
[TBL] [Abstract][Full Text] [Related]
13. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
[TBL] [Abstract][Full Text] [Related]
14. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
15. The carboxy-terminal half of nonstructural protein 3A is not essential for foot-and-mouth disease virus replication in cultured cell lines.
Behura M; Mohapatra JK; Pandey LK; Das B; Bhatt M; Subramaniam S; Pattnaik B
Arch Virol; 2016 May; 161(5):1295-305. PubMed ID: 26935917
[TBL] [Abstract][Full Text] [Related]
16. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
[TBL] [Abstract][Full Text] [Related]
17. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
[TBL] [Abstract][Full Text] [Related]
18. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
19. Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs.
Cao Y; Zhou W; Xing X; Zhang J; Fu Y; Li K; Sun P; Li P; Bai X; Ma X; Bao H; Li D; Chen Y; Lu Z; Liu Z
J Virol Methods; 2018 Dec; 262():26-31. PubMed ID: 30244034
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
